Annual Short Term Debt
$170.10 M
+$700.00 K+0.41%
31 December 2023
Summary:
Neurocrine Biosciences annual short term debt is currently $170.10 million, with the most recent change of +$700.00 thousand (+0.41%) on 31 December 2023. NBIX annual short term debt is now -58.39% below its all-time high of $408.80 million, reached on 31 December 2019.NBIX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
N/A
30 September 2024
Summary:
Neurocrine Biosciences quarterly short term debt is not available.NBIX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | -58.4% | - |
NBIX Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +0.4% | ||
| 5 y | 5 years | -58.4% | +0.4% | ||
| alltime | all time | -58.4% | >+9999.0% |
Neurocrine Biosciences Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $259.00 M(+52.3%) |
| Dec 2023 | $170.10 M(+0.4%) | $170.10 M(-9.4%) |
| Sept 2023 | - | $187.70 M(+0.2%) |
| June 2023 | - | $187.40 M(+10.6%) |
| Dec 2022 | $169.40 M(-58.6%) | $169.40 M(+0.1%) |
| Sept 2022 | - | $169.20 M(-60.2%) |
| Sept 2020 | - | $425.00 M(+1.3%) |
| June 2020 | - | $419.50 M(+2.6%) |
| Dec 2019 | $408.80 M(+5094.4%) | $408.80 M(+6.6%) |
| Sept 2018 | - | $383.65 M(+9379.8%) |
| Sept 2010 | - | $4.05 M(-9.1%) |
| June 2010 | - | $4.45 M(+1.9%) |
| Mar 2010 | - | $4.37 M(-50.9%) |
| Sept 2009 | - | $8.90 M(-42.3%) |
| June 2009 | - | $15.41 M(+1.4%) |
| Mar 2009 | - | $15.20 M(+93.2%) |
| Dec 2008 | $7.87 M(+429.6%) | $7.87 M(+2751.4%) |
| Sept 2008 | - | $276.00 K(-54.1%) |
| June 2008 | - | $601.00 K(-41.4%) |
| Mar 2008 | - | $1.02 M(-31.0%) |
| Dec 2007 | $1.49 M(-66.9%) | $1.49 M(-44.8%) |
| Sept 2007 | - | $2.69 M(-17.7%) |
| June 2007 | - | $3.27 M(-15.6%) |
| Mar 2007 | - | $3.88 M(-13.6%) |
| Dec 2006 | $4.49 M(-22.8%) | $4.49 M(-7.7%) |
| Sept 2006 | - | $4.86 M(-7.3%) |
| June 2006 | - | $5.25 M(-5.4%) |
| Mar 2006 | - | $5.55 M(-4.6%) |
| Dec 2005 | $5.81 M | $5.81 M(-3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2005 | - | $6.05 M(-2.9%) |
| June 2005 | - | $6.23 M(-3.5%) |
| Mar 2005 | - | $6.46 M(-3.2%) |
| Dec 2004 | $6.67 M(+68.5%) | $6.67 M(+40.4%) |
| Sept 2004 | - | $4.75 M(+20.4%) |
| June 2004 | - | $3.95 M(-2.2%) |
| Mar 2004 | - | $4.03 M(+1.9%) |
| Dec 2003 | $3.96 M(+49.0%) | $3.96 M(+15.7%) |
| Sept 2003 | - | $3.42 M(+2.3%) |
| June 2003 | - | $3.34 M(+13.8%) |
| Mar 2003 | - | $2.94 M(+10.6%) |
| Dec 2002 | $2.66 M(+27.4%) | $2.66 M(+19.9%) |
| Sept 2002 | - | $2.22 M(+13.3%) |
| June 2002 | - | $1.96 M(+3.7%) |
| Mar 2002 | - | $1.89 M(-9.6%) |
| Dec 2001 | $2.09 M(+31.5%) | $2.09 M(+23.2%) |
| Sept 2001 | - | $1.69 M(-2.7%) |
| June 2001 | - | $1.74 M(+12.5%) |
| Mar 2001 | - | $1.55 M(-2.5%) |
| Dec 2000 | $1.59 M(+58.7%) | $1.59 M(+38.4%) |
| Sept 2000 | - | $1.15 M(+14.0%) |
| June 2000 | - | $1.01 M(+1.6%) |
| Mar 2000 | - | $990.00 K(-1.0%) |
| Dec 1999 | $1.00 M(+25.0%) | $1.00 M(+11.1%) |
| Sept 1999 | - | $900.00 K(-40.0%) |
| Mar 1999 | - | $1.50 M(+87.5%) |
| Dec 1998 | $800.00 K(-11.1%) | $800.00 K(-11.1%) |
| Dec 1997 | $900.00 K(+12.5%) | $900.00 K(+12.5%) |
| Dec 1996 | $800.00 K | $800.00 K(0.0%) |
| Mar 1996 | - | $800.00 K |
FAQ
- What is Neurocrine Biosciences annual short term debt?
- What is the all time high annual short term debt for Neurocrine Biosciences?
- What is the all time high quarterly short term debt for Neurocrine Biosciences?
What is Neurocrine Biosciences annual short term debt?
The current annual short term debt of NBIX is $170.10 M
What is the all time high annual short term debt for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual short term debt is $408.80 M
What is the all time high quarterly short term debt for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly short term debt is $425.00 M